Rory B. Riggs - Jun 23, 2024 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Jun 23, 2024
Transactions value $
$7
Form type
4
Date filed
6/25/2024, 06:04 PM
Previous filing
Jun 18, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITCI Common Stock Options Exercise +1.57K +1.57% 101K Jun 23, 2024 Direct F1
transaction ITCI Common Stock Options Exercise $337K +20K +19.79% $16.86 121K Jun 24, 2024 Direct F2
transaction ITCI Common Stock Sale -$337K -4.46K -3.69% $75.57 117K Jun 24, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Restricted Stock Units Options Exercise $0 -1.57K -100% $0.00* 0 Jun 23, 2024 Common Stock 1.57K Direct F1, F3
transaction ITCI Stock Option (right to buy) Options Exercise $0 -20K -100% $0.00* 0 Jun 24, 2024 Common Stock 20K $16.86 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On June 24, 2024, the reporting person exercised options to purchase 20,000 shares of common stock that are expiring on June 30, 2024 and the issuer retained 4,462 shares of common stock to pay the exercise price of the options.
F3 On June 23, 2023, the reporting person was granted 1,567 restricted stock units, which vested on the first anniversary of the grant date (June 23, 2024).
F4 This option was granted on June 30, 2014 and will expire on June 30, 2024. All shares underlying this option have vested.